Patent application number | Description | Published |
20090203921 | PROCESSES FOR THE PREPARATION OF INTERMEDIATES OF VALSARTAN - The present invention relates to processes for the preparation of intermediates of valsartan. | 08-13-2009 |
20100004242 | PROCESS FOR THE PREPARATION OF APREPITANT - The present invention relates to a highly pure (2R,3S)-4-benzyl-3-(4-fluorophenyl)morpholin-2-yl 3,5-bis(trifluoromethyl)benzoate of Formula II, and a process for its preparation. The present invention further provides a process for preparation of Aprepitant of Formula I or pharmaceutically acceptable salt thereof, using the highly pure compound of Formula II. The present invention also provides a process for preparation of Aprepitant of Formula I or pharmaceutically acceptable salt thereof which comprises of cyclising the compound of Formula VII at elevated temperature, in the absence of solvent. | 01-07-2010 |
20120178821 | POLYMORPHIC FORM OF TOREMIFENE CITRATE AND PROCESS FOR ITS PREPARATION - The present invention provides a polymorphic form of toremifene citrate and processes for its preparation. It also relates to an improved process for the preparation of the Z isomer of the toremifene base, free of E isomer, and its pharmaceutically acceptable salts. | 07-12-2012 |
20120184750 | PROCESS FOR THE PREPARATION OF OLMESARTAN MEDOXOMIL - The present invention provides an improved process for the preparation of olmesartan medoxomil, which is free of OLM-acid and has lower amount of eliminate and acetic acid impurity. | 07-19-2012 |
20120184751 | POLYMORPHIC FORM OF OLMESARTAN MEDOXOMIL - The present invention relates to a polymorphic form of olmesartan medoxomil and a process for the preparation of crystalline olmesartan medoxomil. | 07-19-2012 |
20120277426 | PROCESS FOR THE PREPARATION OF CRYSTALLINE APREPITANT HAVING FORM I CONTENT - The present invention provides a process for preparation of crystalline aprepitant having not more than 15% by weight of Form I content which comprises, a) dissolving aprepitant in a suitable solvent to obtain a solution, b) cooling the solution to 10-15° C., c) optionally seeding the solution with aprepitant Form I crystals, d) adding an anti-solvent to the solution, and e) isolating crystalline aprepitant having not more than 15% by weight of Form I content. | 11-01-2012 |
20130245278 | PROCESS FOR THE PREPARATION OF FEBUXOSTAT - An improved and efficient process for the preparation of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid (febuxostat) that is substantially free from amide by-product is provided. | 09-19-2013 |
20150329526 | PROCESS FOR THE PREPARATION OF PAZOPANIB OR SALTS THEREOF - The present invention provides a process for the preparation of pazopanib of Formula Ia or salts, and intermediates thereof. | 11-19-2015 |